source
- AstraZeneca's oral relaxin agonist shows positive phase 2b results in chronic heart failureAstraZeneca presented phase 2b data from its Luminara trial at the European Society of Cardiology Congress in Munich. The study evaluated the oral relaxin agonist AZD5462 in patients with chronic h…
- Verily, NVIDIA and NIH launch first multimodal AI model combining EHR and genomicsVerily Health, in partnership with NVIDIA and the NIH All of Us Research Program, announced the development of a new foundation model that merges electronic health record data with genomic informat…